GT-02329

N/A

Report date: 2023/04/23 16:11:25
NME

Base Information

Drug NameGT-02329
Drug Alias NameGT-02329
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucosylceramidase stimulants
TargetsGlucosylceramidase
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGain Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A